CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Oxazepam

奥沙西泮 杂质对照品Oxazepam Impurities

EP34 个杂质条目34 impurity entries

本页汇总 奥沙西泮 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Oxazepam with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 奥沙西泮(Oxazepam)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesCharacterisation of oxazepam degradation products by high-performance liquid chromatography/electrospray ionisation mass spectrometry and electrospray ionisation quadrupole time-of-flight tandem mass spectrometry
    Rapid communications in mass spectrometry : RCM · 2010 · Smyth TJ et al.  ·  PMID 20155776  ·  DOI
  2. 杂质研究Impurity studiesStability-indicating high-performance liquid chromatographic assay for oxazepam tablets and capsules
    Journal of pharmaceutical sciences · 1983 · Reif VD, DeAngelis NJ  ·  PMID 6644597  ·  DOI
  3. 杂质研究Impurity studiesChanges in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643
    Carcinogenesis · 2003 · Iida M et al.  ·  PMID 12727805  ·  DOI
  4. 杂质研究Impurity studies[Genotoxicity of oxazepam--the micronucleus cytochalasin-B test]
    Medicinski arhiv · 2002 · Ibrulj S, Duricić E  ·  PMID 12014096
  5. 分析方法Analytical MethodsPolarographic determination of oxazepam
    Journal of pharmaceutical sciences · 1969 · Fazzari FR, Riggleman OH  ·  PMID 5353275  ·  DOI

奥沙西泮 —— 原料药与杂质对照品Oxazepam — drug substance & impurities

共 34 个条目(含原料药本体)34 items incl. the drug substance
Oxazepam Impurity 1 (Oxazepam EP Impurity A) structure
EPA
奥沙西泮杂质1(奥沙西泮EP杂质A)Oxazepam Impurity 1 (Oxazepam EP Impurity A)
Oxazepam Impurity 1 (Oxazepam EP Impurity A)
CAS No.19554-95-1
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 3 (Oxazepam EP Impurity C) structure
EPC
奥沙西泮杂质3(奥沙西泮EP杂质C)Oxazepam Impurity 3 (Oxazepam EP Impurity C)
Oxazepam Impurity 3 (Oxazepam EP Impurity C)
CAS No.5958-05-4
Chemical FormulaC15H9ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 5 (Oxazepam EP Impurity E) structure
EPE
奥沙西泮杂质5(奥沙西泮EP杂质E)Oxazepam Impurity 5 (Oxazepam EP Impurity E)
Oxazepam Impurity 5 (Oxazepam EP Impurity E)
CAS No.963-39-3
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 6 structure
6
奥沙西泮杂质6Oxazepam Impurity 6
Oxazepam Impurity 6
CAS No.5163-21-3
Chemical FormulaC15H13ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 7 structure
7
奥沙西泮杂质7Oxazepam Impurity 7
Oxazepam Impurity 7
CAS No.6801-81-6
Chemical FormulaC21H19ClN2O8
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 8 structure
8
奥沙西泮杂质8Oxazepam Impurity 8
Oxazepam Impurity 8
CAS No.52432-54-9
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 9 structure
9
奥沙西泮杂质9Oxazepam Impurity 9
Oxazepam Impurity 9
CAS No.40762-00-3
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 10 structure
10
奥沙西泮杂质10Oxazepam Impurity 10
Oxazepam Impurity 10
CAS No.5504-71-2
Chemical FormulaC15H13ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 11 structure
11
奥沙西泮杂质11Oxazepam Impurity 11
Oxazepam Impurity 11
CAS No.4700-56-5
Chemical FormulaC19H15ClN2O5
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 12 structure
12
奥沙西泮杂质12Oxazepam Impurity 12
Oxazepam Impurity 12
CAS No.5958-08-7
Chemical FormulaC15H9ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 13 structure
13
奥沙西泮杂质13Oxazepam Impurity 13
Oxazepam Impurity 13
CAS No.5628-03-5
Chemical FormulaC15H12ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 14 structure
14
奥沙西泮杂质14Oxazepam Impurity 14
Oxazepam Impurity 14
CAS No.10456-82-3
Chemical FormulaC15H12ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 15 structure
15
奥沙西泮杂质15Oxazepam Impurity 15
Oxazepam Impurity 15
CAS No.38283-41-9
Chemical FormulaC21H23ClN5O2+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 16 structure
16
奥沙西泮杂质16Oxazepam Impurity 16
Oxazepam Impurity 16
CAS No.36270-93-6
Chemical FormulaC15H13ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 21 structure
21
奥沙西泮杂质21Oxazepam Impurity 21
Oxazepam Impurity 21
CAS No.34790-74-4
Chemical FormulaC15H10Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 2-d5 structure
2-D5
奥沙西泮杂质2-d5Oxazepam Impurity 2-d5
Oxazepam Impurity 2-d5
CAS No.65854-77-5
Chemical FormulaC17H8D5ClN2O3
Purity>95%询价On request
Oxazepam Impurity 25 structure
25
奥沙西泮杂质25Oxazepam Impurity 25
Oxazepam Impurity 25
CAS No.88190-77-6
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 26 structure
26
奥沙西泮杂质26Oxazepam Impurity 26
Oxazepam Impurity 26
CAS No.17954-62-0
Chemical FormulaC14H11ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 27 structure
27
奥沙西泮杂质27Oxazepam Impurity 27
Oxazepam Impurity 27
CAS No.18878-19-8
Chemical FormulaC16H13ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 28 structure
28
奥沙西泮杂质28Oxazepam Impurity 28
Oxazepam Impurity 28
CAS No.5628-00-2
Chemical FormulaC17H14ClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 29 structure
29
奥沙西泮杂质29Oxazepam Impurity 29
Oxazepam Impurity 29
CAS No.21882-29-1
Chemical FormulaC14H11ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 34 structure
34
奥沙西泮杂质34Oxazepam Impurity 34
Oxazepam Impurity 34
CAS No.20805-68-9
Chemical FormulaC13H11N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 35 structure
35
奥沙西泮杂质35Oxazepam Impurity 35
Oxazepam Impurity 35
CAS No.156052-65-2
Chemical FormulaC13H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 36 structure
36
奥沙西泮杂质36Oxazepam Impurity 36
Oxazepam Impurity 36
CAS No.855288-90-3
Chemical FormulaC14H12N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 37 structure
37
奥沙西泮杂质37Oxazepam Impurity 37
Oxazepam Impurity 37
CAS No.2246723-40-8
Chemical FormulaC14H12ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 38 structure
38
奥沙西泮杂质38Oxazepam Impurity 38
Oxazepam Impurity 38
CAS No.2246723-47-5
Chemical FormulaC14H12ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 39 structure
39
奥沙西泮杂质39Oxazepam Impurity 39
Oxazepam Impurity 39
CAS No.106351-41-1
Chemical FormulaC14H12ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 40 structure
40
奥沙西泮杂质40Oxazepam Impurity 40
Oxazepam Impurity 40
CAS No.886364-21-2
Chemical FormulaC14H19ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 41 structure
41
奥沙西泮杂质41Oxazepam Impurity 41
Oxazepam Impurity 41
CAS No.180039-99-0
Chemical FormulaC17H16N2O
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 42 structure
42
奥沙西泮杂质42Oxazepam Impurity 42
Oxazepam Impurity 42
CAS No.1295585-09-9
Chemical FormulaC16H15ClN2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 43 structure
43
奥沙西泮杂质43Oxazepam Impurity 43
Oxazepam Impurity 43
CAS No.5497-11-0
Chemical FormulaC17H15ClN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 44 structure
44
奥沙西泮杂质44Oxazepam Impurity 44
Oxazepam Impurity 44
CAS No.2866-82-2
Chemical FormulaC13H10ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 45 structure
45
奥沙西泮杂质45Oxazepam Impurity 45
Oxazepam Impurity 45
CAS No.30739-34-5
Chemical FormulaC15H11ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Oxazepam Impurity 47 structure
47
奥沙西泮杂质47Oxazepam Impurity 47
Oxazepam Impurity 47
CAS No.62770-20-1
Chemical FormulaC15H13ClN2O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

奥沙西泮 —— 研究文献与合成路线Oxazepam — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 奥沙西泮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Oxazepam. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Characterisation of oxazepam degradation products by high-performance liquid chromatography/electrospray ionisation mass spectrometry and electrospray ionisation quadrupole time-of-flight tandem mass spectrometry
    Smyth TJ, Rodríguez Robledo V, Smyth WF · Rapid communications in mass spectrometry : RCM · 2010 · 被引 6cited 6
  2. [Characterization of lorazepam and oxazepam by the thermal behavior of their degradation product]
    Chauvet A · Annales pharmaceutiques francaises · 1995 · 被引 1cited 1
  3. Stability-indicating high-performance liquid chromatographic assay for oxazepam tablets and capsules
    Reif VD, DeAngelis NJ · Journal of pharmaceutical sciences · 1983 · 被引 2cited 2
  4. Simultaneous determination of N-butylscopolamine and oxazepam in pharmaceutical formulations by first-order digital derivative spectrophotometry
    Toral MI, Muñoz MA, Orellana SL · Journal of AOAC International · 2005 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. Oxazepam dripping pills and preparation thereof
    QIAN JIN, XU JUN, PENG HONG · 公开号 CN1543961CN1543961 · 2004

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

奥沙西泮 杂质谱研究要点Oxazepam — impurity profiling notes

下面这些是拿到 奥沙西泮 的 34 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 34 impurity entries for Oxazepam, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances